Liver Disease
From the Journals
Year-long synbiotic regimen fails to improve NAFLD
Mean liver fat content was reduced by 4% in the synbiotic group, compared with 6% in the placebo group, a difference that was not statistically...
From the Journals
Noninvasive fibrosis scores not sensitive in people with fatty liver disease and T2D
Alternatives to liver biopsy are less than ideal for detecting advanced fibrosis in patients with underlying diabetes.
News
AASLD: Liver transplants should proceed despite COVID-19
Immunosuppression may be protective; the advice comes from a document a recently released from AASLD to help hepatologists and liver transplant...
Latest News
Patients with COVID-19 may face risk for liver injury
Mechanisms of damage remain unclear, but could include virus-, immune-, or drug-induced injury.
Conference Coverage
Stick with the full 12-week DAA course for acute HCV
From the Journals
Liver cancer risk reduced by aspirin in chronic viral hepatitis
Patients taking low-dose aspirin had a 31% lower risk of hepatocellular carcinoma.
From the Journals
Belapectin misses endpoints in NASH trial
A post-hoc subgroup analysis suggested a benefit for patients without esophageal varices.
From the Journals
Screen all adults for hepatitis C, says USPSTF
The U.S. Preventive Services Task Force now recommends that asymptomatic adults ages 18-79 be screened for hepatitis C virus infection.
Conference Coverage
Rising number of young people dying after heavy drinking
This highlights the importance of asking for details about alcohol use during primary care visits.
Conference Coverage
HBV: Rethink the free pass for immune tolerant patients
MAUI, HAWAII – Not treating means more liver cancer.